Approval for acrysof restor natural intraocular lens (iol) models sn60d3 and mn60d3 (level a modification: addition of chromophore).  The device, as modified, will be marketed under the trade name acrysof restor natural iol and is indicated for primary implantation for the visual correction of aphakia secondary to the removal of a cataractous lens in adult patients with or without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence.  The lens is intended to be placed in the capsular bag.